IsomiRs and tRNA-derived fragments are associated with metastasis and patient survival in uveal melanoma.


Journal

Pigment cell & melanoma research
ISSN: 1755-148X
Titre abrégé: Pigment Cell Melanoma Res
Pays: England
ID NLM: 101318927

Informations de publication

Date de publication:
01 2020
Historique:
received: 29 03 2019
revised: 22 05 2019
accepted: 10 06 2019
pubmed: 10 7 2019
medline: 11 11 2020
entrez: 9 7 2019
Statut: ppublish

Résumé

Uveal melanoma (UVM) is the most common primary intraocular malignancy in adults. With over 50% of patients developing metastatic disease, there is an unmet need for improved diagnostic and therapeutic options. Efforts to understand the molecular biology of the disease have revealed several markers that correlate with patient prognosis, including the copy number of chromosome 3, genetic alterations in the BAP1, EIF1AX and SF3B1 genes, and other transcriptional features. Here, we expand upon previous reports by comprehensively characterizing the short RNA-ome in 80 primary UVM tumor samples. In particular, we describe a previously unseen complex network involving numerous regulatory molecules that comprise microRNA (miRNAs), novel UVM-specific miRNA loci, miRNA isoforms (isomiRs), and tRNA-derived fragments (tRFs). Importantly, we show that the abundance profiles of isomiRs and tRFs associate with various molecular phenotypes, metastatic disease, and patient survival. Our findings suggest deep involvement of isomiRs and tRFs in the disease etiology of UVM. We posit that further study and characterization of these novel molecules will improve understanding of the mechanisms underlying UVM, and lead to the development of new diagnostic and therapeutic approaches.

Identifiants

pubmed: 31283110
doi: 10.1111/pcmr.12810
pmc: PMC6928426
mid: NIHMS1040446
doi:

Substances chimiques

Biomarkers, Tumor 0
MicroRNAs 0
RNA, Transfer 9014-25-9

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

52-62

Subventions

Organisme : NCI NIH HHS
ID : R21 CA195204
Pays : United States
Organisme : NCI NIH HHS
ID : R21CA195204
Pays : United States

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Cell. 2015 May 7;161(4):790-802
pubmed: 25957686
Sci Rep. 2017 Feb 21;7:41184
pubmed: 28220888
Science. 2012 Apr 13;336(6078):237-40
pubmed: 22499947
Science. 2008 Sep 12;321(5895):1490-2
pubmed: 18787168
BioDrugs. 2016 Jun;30(3):161-72
pubmed: 27000042
BMC Biol. 2014 Oct 01;12:78
pubmed: 25270025
Sci Rep. 2018 Mar 28;8(1):5314
pubmed: 29593348
Cancer Cell. 2018 Jan 8;33(1):151
pubmed: 29316429
Nucleic Acids Res. 2015 Oct 30;43(19):9158-75
pubmed: 26400174
Nucleic Acids Res. 2015 Jan;43(Database issue):D141-5
pubmed: 25392422
Oncogene. 2012 Mar 22;31(12):1558-70
pubmed: 21860416
Arch Ophthalmol. 2009 Aug;127(8):989-98
pubmed: 19667335
Nucleic Acids Res. 2012 Jan;40(1):37-52
pubmed: 21911355
Nature. 2008 Oct 23;455(7216):1124-8
pubmed: 18806776
Cell. 2017 Jun 29;170(1):61-71.e11
pubmed: 28666125
Mol Syst Biol. 2006;2:46
pubmed: 16969338
RNA. 2018 Aug;24(8):1093-1105
pubmed: 29844106
Oncotarget. 2015 Sep 22;6(28):24797-822
pubmed: 26325506
Ophthalmology. 2015 Jun;122(6):1180-6
pubmed: 25813452
Oncotarget. 2014 Sep 30;5(18):8790-802
pubmed: 25229428
Nucleic Acids Res. 2017 Apr 7;45(6):2973-2985
pubmed: 28206648
Clin Epigenetics. 2016 Jul 22;8:80
pubmed: 27453764
Eye (Lond). 2017 Feb;31(2):241-257
pubmed: 27911450
Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):E1106-15
pubmed: 25713380
RNA. 2014 Sep;20(9):1431-9
pubmed: 24984703
BMC Genomics. 2016 Aug 08;17:566
pubmed: 27502506
Ophthalmology. 2017 May;124(5):609-618
pubmed: 28159380
Bioinformatics. 2011 Apr 1;27(7):1011-2
pubmed: 21278192
Cell. 2009 Jan 23;136(2):215-33
pubmed: 19167326
Oncogene. 2016 Oct 20;35(42):5501-5514
pubmed: 27065335
Ophthalmology. 2017 Oct;124(10):1523-1531
pubmed: 28495150
Wiley Interdiscip Rev RNA. 2011 Nov-Dec;2(6):853-62
pubmed: 21976287
RNA. 2017 Feb;23(2):161-168
pubmed: 27879434
Ophthalmology. 2013 Oct;120(10):2066-71
pubmed: 23664467
Sci Rep. 2014 Aug 08;4:5947
pubmed: 25103560
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
pubmed: 11309499
Bioinformatics. 2017 Jul 1;33(13):2034-2036
pubmed: 28203700
Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):E3816-25
pubmed: 26124144
RNA. 2009 Dec;15(12):2147-60
pubmed: 19850906
Nucleic Acids Res. 2018 Jan 4;46(D1):D152-D159
pubmed: 29186503
RNA Biol. 2017 Oct 3;14(10):1364-1373
pubmed: 27892771
Genes Dev. 2009 Nov 15;23(22):2639-49
pubmed: 19933153
Cancer Res. 2018 Mar 1;78(5):1140-1154
pubmed: 29229607
BMC Bioinformatics. 2016 Mar 10;17:123
pubmed: 26961774

Auteurs

Eric Londin (E)

Computational Medicine Center, Thomas Jefferson University, Philadelphia, Pennsylvania.

Rogan Magee (R)

Computational Medicine Center, Thomas Jefferson University, Philadelphia, Pennsylvania.

Carol L Shields (CL)

Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.

Sara E Lally (SE)

Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.

Takami Sato (T)

Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.

Isidore Rigoutsos (I)

Computational Medicine Center, Thomas Jefferson University, Philadelphia, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH